Kestra Private Wealth Services, LLC Curis Inc Transaction History

Kestra Private Wealth Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$0.47 - $17.22 $1,388 - $50,885	-2,955 Reduced 7.25%	37,787 $20,000
Q3 2022 Nov 14, 2022	BUY	$0.74 - $15.01 $2,186 - $44,354	2,955 Added 7.82%	40,742 $29,000
Q4 2021 Jan 21, 2022	SELL	$4.45 - $8.09 $21,119 - $38,395	-4,746 Reduced 11.16%	37,787 $179,000
Q3 2021 Oct 21, 2021	SELL	$6.94 - $8.85 $48 - $61	-7 Reduced 0.02%	42,533 $333,000
Q1 2021 May 11, 2021	BUY	$8.78 - $12.8 $373,501 - $544,512	42,540 New	42,540 $481,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Kestra Private Wealth Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Private Wealth Services, LLC with notifications on news.